Hälsa & medicin

A major review of studies shows that combining cognitive and motor exercises significantly improves dual-task performance in Parkinson's disease patients—the ability to do two things at once, like walking while talking. The finding has implications for treatment protocols and could reduce fall risk and disability in a growing patient population.EN

A major review of Enhanced Recovery After Surgery (ERAS) protocols spanning 20+ years reveals their continued impact on patient outcomes, yet researchers are signaling the need for next-generation improvements. For hospitals and surgical centers, the findings suggest current ERAS frameworks have matured—and that competitive advantage now lies in what comes next.EN

Clinicians in Sweden have reported a meningitis infection caused by Streptococcus pseudopneumoniae, a pathogen rarely associated with severe brain infections. The case documentation adds to limited knowledge about this bacterium's disease potential and could inform diagnostic protocols for similar presentations across healthcare systems.EN

Researchers have identified immune factors in blood plasma that signal whether advanced lung cancer patients will stop responding to osimertinib, a leading targeted therapy. The discovery could help oncologists switch treatments earlier, potentially improving survival—and reducing wasted spending on ineffective drugs.EN

A major clinical trial found that daratumumab combined with lenalidomide and dexamethasone improved outcomes for multiple myeloma patients at initial diagnosis. The results could reshape treatment protocols and expand the addressable market for these therapies across oncology practices and hospital systems.EN

An international expert panel using formal consensus methods found significant disagreement on how to surgically manage splenic flexure carcinoma, a rare colon cancer. The lack of standardized guidelines could lead to inconsistent treatment outcomes and complications, highlighting a gap in surgical oncology standards that healthcare systems and insurers need to address.EN

Researchers have found that patient age significantly influences both treatment selection and survival rates in esophagogastric cancers, according to new data presented at the American Society of Clinical Oncology. The findings suggest oncology practices and healthcare systems may need to reconsider age-based treatment protocols to optimize outcomes across patient populations.EN

A new analysis confirms that low vitamin D correlates with poor health outcomes, but researchers caution against assuming the vitamin itself is the culprit. The distinction matters for supplement makers, insurers, and policymakers betting billions on vitamin D interventions—many may be addressing a symptom rather than a root cause.EN

Researchers have synthesized decades of data on labor progression patterns, offering clearer benchmarks for clinicians. The findings could reshape delivery protocols and reduce unnecessary interventions—affecting hospital practices, liability exposure, and maternal outcomes across healthcare systems.EN

A major analysis confirms that regular physical activity significantly lowers the risk of heart disease, cancer, and premature death. For insurers, employers, and public health planners, the findings quantify just how much activity matters—and suggest where prevention efforts should focus to reduce healthcare costs.EN

A new editorial in Frontiers in Pharmacology examines safety gaps in COVID-19 drug management, signaling growing concern among clinicians about medication mistakes during the pandemic. For hospital administrators and health systems, the findings underscore the need for better pharmacy oversight and clinical protocols to reduce costly adverse events and liability.EN

Researchers combined traditional cancer surgery with a new drug-delivery technique that sprays chemotherapy directly into the abdomen during laparoscopic procedures. The feasibility study suggests this approach could reduce recurrence risk in high-risk gastric cancer patients, potentially opening a new treatment pathway for oncology centers and pharmaceutical companies focused on advanced drug-delivery systems.EN

A new analysis examines whether indirect calorimetry—a test measuring how many calories patients burn—should become standard care or remain reserved for specific cases. The answer could reshape nutrition protocols in hospitals and care facilities, affecting both patient outcomes and operational costs.EN

Researchers have identified a more effective pathway for detecting atrial fibrillation, the irregular heartbeat condition affecting millions globally. The finding matters to insurers, hospital systems, and policymakers because earlier detection can prevent costly strokes and complications, potentially reducing healthcare spending and improving patient outcomes.EN

A new study finds that infants born prematurely or with low birth weight face significantly higher risk of developing nonalcoholic fatty liver disease later in life. The finding suggests that early-life conditions may have lasting metabolic consequences, potentially expanding the window for preventive health interventions and affecting how clinicians assess disease risk.EN

Researchers analyzed decades of workplace mental health programs and found that targeted interventions work better than company-wide initiatives. The findings matter because employers waste billions on ineffective wellness programs—this guide shows where to focus investment for measurable results.EN

Researchers have identified how bladder cancer tumors turn on telomerase—a cellular mechanism that allows cancer cells to divide indefinitely. The discovery could enable doctors to better predict which patients need aggressive treatment and potentially develop new drugs targeting this vulnerability.EN

Researchers have identified how citrullination—a protein modification process—drives inflammation at the skin barrier. The finding could open new treatment pathways for chronic skin conditions affecting millions and create commercial opportunities for companies developing targeted therapies.EN

A new study challenges one-size-fits-all dietary advice for chronic kidney disease patients, finding that the type of fish consumed—particularly its depth origin—affects health outcomes. The finding could reshape dietary guidelines and pharmaceutical company strategies around renal nutrition products.EN

A new study reveals that screening programs for atrial fibrillation — a common heart rhythm disorder — produce unequal results depending on patient characteristics. The finding matters for healthcare systems and insurers designing screening initiatives, suggesting a one-size-fits-all approach may waste resources while missing high-risk populations.EN

A comprehensive review finds that sarcoidosis—a chronic inflammatory disease affecting thousands—lacks biomarkers for early detection or prognosis, forcing doctors to rely on multiple imaging and tissue tests. For drugmakers and diagnostics firms, this diagnostic gap represents both a clinical need and a commercial opportunity in a disease where misdiagnosis is common.EN

A comprehensive analysis of 47 studies reveals elevated concentrations of metals in cerebrospinal fluid and blood of ALS patients compared to healthy controls. The findings could reshape diagnostic approaches and point toward environmental or occupational factors that may trigger the fatal neurological disease.EN

Hepatologists are moving toward population-level approaches to liver disease management rather than treating patients one at a time. The shift reflects a growing recognition that liver health outcomes depend on broader public health infrastructure, clinical coordination, and preventive strategies—a change with significant implications for healthcare policy and resource allocation.EN

Researchers are making progress using cell sheets—layers of living cells—to rebuild heart tissue damaged by heart attacks and disease. The approach could eventually offer patients an alternative to transplants and significantly expand the market for regenerative medicine therapies.EN

A major review of cognitive behavior therapy for depression found consistent evidence of effectiveness across routine clinical settings—not just controlled studies. For healthcare systems and insurers weighing mental health investments, the findings suggest CBT delivers measurable results when delivered in everyday practice, supporting budget allocation decisions.EN